Skip to Content Facebook Feature Image

Northwell’s Feinstein Institutes’ Dr. Kevin J. Tracey receives Cold Spring Harbor Laboratory Double Helix Medal

Business

Northwell’s Feinstein Institutes’ Dr. Kevin J. Tracey receives Cold Spring Harbor Laboratory Double Helix Medal
Business

Business

Northwell’s Feinstein Institutes’ Dr. Kevin J. Tracey receives Cold Spring Harbor Laboratory Double Helix Medal

2026-11-16 22:21 Last Updated At:22:30

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Nov 16, 2026--

Recognized as the founding father of bioelectronic medicine, Kevin J. Tracey, MD, president and CEO of Northwell Health’sFeinstein Institutes for Medical Research, received the prestigious Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on November 10. The honor celebrates his decades-long pursuit of unraveling the mysteries of the brain's connection to the body and the role of the nervous system in controlling inflammation, research that has given rise to an entirely new field of medicine. Dr. Tracey was honored alongside philanthropist Michael Milken at the Double Helix Medals Dinner in New York City.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116692063/en/

The Double Helix Medal, one of biology’s most distinguished honors, recognizes individuals who have made transformative breakthroughs in biomedical research, as well as those who have significantly supported and raised awareness of advances in science and medicine. Past recipients include Muhammad Ali, Michael J. Fox, Kareem Abdul-Jabbar, Katie Couric, Marlo Thomas, and Nobel laureates Jennifer Doudna, Katalin Karikó and Jim Allison, among other luminaries in science, medicine, philanthropy and public life.

“I am honored to receive the Double Helix Medal and to join a group of scientists and leaders I have long admired,” said Dr. Tracey, Karches Family Distinguished Chair in Medical Research. “This recognition also belongs to my colleagues in the lab and in industry and to the physicians and patients who took a chance on a new idea. That idea is now a treatment, and it is also a new beginning.”

Dr. Tracey is widely recognized as the pioneer of bioelectronic medicine; an innovative field of medicine that combines neuroscience, molecular medicine and bioengineering to explore how devices and other technologies can harness the body’s own systems to cure disease. His landmark 2002 discovery, published in Nature, revealed the “inflammatory reflex,” the mechanism by which the vagus nerve regulates the body’s immune response and controls inflammation. This discovery laid the scientific groundwork for the development of implantable devices that can treat chronic inflammatory diseases such as rheumatoid arthritis, Crohn’s disease and sepsis without the use of drugs.

Dr. Tracey’s research directly inspired the development of the 2025 FDA-approved SetPoint Medical device for rheumatoid arthritis, the first non-pharmacologic bioelectronic therapy for the condition, representing the ultimate realization of bench-to-bedside science. Northwell was the first health system in the nation to implant the SetPoint System.

Under Dr. Tracey’s leadership, the Feinstein Institutes has grown into the global scientific home of bioelectronic medicine, encompassing six institutes, with more than 50 research labs and 5,000 researchers and staff dedicated to producing knowledge to cure disease.

“Dr. Tracey's recognition by Cold Spring Harbor Laboratory is incredibly well-deserved and a testament to what is possible when an organization invests in research for the long term,” said John D’Angelo, MD, Northwell’s president and CEO. “His discovery of the inflammatory reflex gave rise to an entirely new field of medicine, one that is delivering life-changing results for patients right now. This is precisely why we invest in science that challenges the boundaries of what medicine can do.”

Throughout his career, Dr. Tracey has received honors recognizing his scientific contributions, including being named an “Innovator” on TIME’s 2026 TIME100 Health list. He was elected as a Fellow of the Royal Swedish Academy of Engineering Sciences – one of the highest honors for engineers and scientists in Sweden and internationally – and inducted as a Fellow of the National Academy of Inventors (NAI) Class of 2025, the highest professional distinction awarded solely to inventors, recognized specifically for his discovery of the inflammatory reflex and his founding of the field of bioelectronic medicine.

Under his leadership, the Feinstein Institutes has also earned significant institutional recognition, with the double neural bypass named to TIME’s Hall of Fame and TIME’s Best Inventions of 2024, and Northwell Health named to TIME100 Most Influential Companies 2025.

Dr. Tracey is also the author of The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes, further cementing his role as a leading voice in translating complex science for the benefit of patients and the public.

Founded in 1890, Cold Spring Harbor Laboratory is considered the birthplace of molecular biology and home to eight Nobel Prize winners. Nature has recognized CSHL as the world’s leading academic research institution for scientific impact, describing it as a “hub of breakthroughs.” The annual Double Helix Medals Dinner brought together more than 450 leaders in science, medicine, and philanthropy to celebrate visionary contributions to human health and biology.

About the Feinstein Institutes

The Feinstein Institutes for Medical Researchis the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journalsMolecular MedicineandBioelectronic Medicine. Through theElmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visithttp://feinstein.northwell.eduand follow us onLinkedIn.

(Left to right) John D'Angelo, MD, president and CEO of Northwell Health; Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes for Medical Research; and Bruce Stillman, PhD, president and CEO of Cold Spring Harbor Laboratory pose at the annual Double Helix Medals Dinner on November 10, 2026. (Photo credit: Donna Alberico)

(Left to right) John D'Angelo, MD, president and CEO of Northwell Health; Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes for Medical Research; and Bruce Stillman, PhD, president and CEO of Cold Spring Harbor Laboratory pose at the annual Double Helix Medals Dinner on November 10, 2026. (Photo credit: Donna Alberico)

WASHINGTON (AP) — President Donald Trump is preparing to depart for Asia on Monday, turning his focus to economic deals and historic three-way nuclear talks with Russia and China as his administration adjusts to a new political reality in Washington.

Trump’s departure comes after the often-omnipresent president had remained largely out of public sight for the past several days, even as a nationwide ground stop snarled air traffic and his Republican administration faced tough questions on its handling of the situation.

His trip to Asia, which begins in Manila then continues to the Chinese tech hub of Shenzhen, gives Trump the opportunity to change the narrative from his domestic woes, including the air travel problems and fallout from the November midterm election where his party lost both chambers of Congress.

The controversy over tech powerhouse and chipmaker Nvidia is also certain to hang over Trump’s visit to China, despite efforts by administration officials to downplay the president’s close ties to Jensen Huang, who resigned as CEO last week after admitting to an affair with an alleged Chinese government agent.

Beijing has said it was not involved. Trump had no plans to raise the issue with Chinese President Xi Jinping when the two leaders meet, said U.S. officials who briefed reporters anonymously about the president’s Asia trip under ground rules set by the White House.

Huang accompanied Trump on Air Force One during the president’s last trip to China in May, and he has been a sporadic presence around Trump at the White House while speaking to him frequently. Trump has argued that America needs to preserve its leadership on artificial intelligence, and warned of dire consequences if China wins that competition.

Scrutiny of the Trump administration’s actions as they relate to Nvidia has been growing, including on the Commerce Department’s delay in placing restrictions on Nvidia chip exports to a company led by the alleged Chinese spy with whom Huang had the affair.

Asked about the matter in an interview that aired Sunday with Fox News Channel anchor Larry Kudlow, Treasury Secretary Scott Bessent said he will “leave the internal workings of the Commerce Department to the Commerce Department.

“I think what’s more important here, Larry, is to examine whether Nvidia had a culture of compliance around the U.S. export restrictions ... and at what level?” Bessent said.

He added: “I think we’re going to see answers.”

“Jensen Huang is an incredible innovator, but that does not abrogate their duties of compliance,” Bessent said.

Among the travelers on the Asia trip with Trump will be Elon Musk, the head of SpaceX and Tesla, who is shaping up to be a top investigative target of the incoming Democratic majority in Congress.

In the Philippines, Trump will meet with Southeast Asian leaders who look to the United States for help countering Beijing’s aggression in the region. He plans to sign a trade deal with Thailand while in Manila, the White House said.

Then he heads to China for the Asia-Pacific Economic Cooperation summit — and at the end of the trip, the first-ever three-way talks with China's Xi and Russian President Vladimir Putin to discuss nuclear stockpiles.

Trump and U.S. officials have indicated that the meeting with Putin and Xi will focus on nuclear weapons and that topics of discussion would not include Russia's war in Ukraine, now in its fifth year. Still, the president has recently played up chances for a settlement to the conflict.

The three-way meeting will also put in the spotlight the ongoing U.S. war with Iran, a country which has often allied with China and Russia. The war has been widely blamed for the Republican Party’s steep losses in the midterms, and while Trump has tried to play down the chances he will order a resumption of major strikes against Iran, he also has said he does not see the need for talks.

China’s Foreign Ministry spokesperson Mao Ning said Monday that the trilateral talks would be of “groundbreaking significance” and that China aimed to have in-depth exchanges about safeguarding world peace and promoting stability.

“Under the current circumstances, the three countries shoulder an important responsibility to work together in addressing global challenges,” she said in a regular briefing in Beijing.

President Donald Trump speaks before signing an executive order in the Oval Office of the White House Thursday, Nov. 5, 2026, in Washington. (AP Photo/Alex Brandon)

President Donald Trump speaks before signing an executive order in the Oval Office of the White House Thursday, Nov. 5, 2026, in Washington. (AP Photo/Alex Brandon)

Recommended Articles